MedTrace Logo

COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality

NCT04390074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9905

Last updated 2020-08-25

No results posted yet for this study

Summary

The Corona virus disease 2019 (COVID-19) pandemic is currently involving all parts of the world. Several risk factors for critical illness and death from the disease have been proposed. However, the observed associations between different comorbidities and chronic medications have not fully been related to the frequencies of the same comorbidities and chronic medications in age- and sex-matched controls from the general population. This is important since some of the proposed risk factors are very common in the aged who, by age alone, are more prone to a more severe course of the disease.

By combining several registries, we will compare, on several comorbidities such as hypertension and diabetes and several medications such as immunosuppressant drugs and Angiotensin Converting Enzyme (ACE)-inhibitors, the first 2000 cases of COVID-19 patients receiving critical care in Sweden to a set 8000 age- and sex-matched controls.

Conditions

Interventions

OTHER

COVID-19 and Intensive Care

No intervention, observational.

Sponsors & Collaborators

  • Center for Clinical Research Dalarna, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Miklos Lipcsey, PhD · Uppsala University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2020-06-04
Completion
2020-06-04

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04390074 on ClinicalTrials.gov